by Primrose Bio | May 20, 2025 | Scientific Posters
ABSTRACT: RNA has emerged as a critical tool in modern biotechnology and therapeutics, with applications ranging from vaccine development to gene therapy. mRNA is synthesized by in vitro transcription using single-subunit RNA polymerases, whose performance directly... 
by Primrose Bio | May 17, 2025 | Events
Primrose Bio exhibited at PEGS Boston 2025 from May 12–16, highlighting advancements in complex protein development powered by our proprietary Pfenex Expression Technology® and Pfast™ Feasibility platform. On May 12, Russell... 
by Primrose Bio | May 12, 2025 | Scientific Posters
ABSTRACT: Primrose Bio’s Pfenex Expression Technology® (Pfenex) platform has established itself as a robust, scalable solution for recombinant protein production, as evidenced by its role in six commercially approved products. Integrating sophisticated... 
by Primrose Bio | May 7, 2025 | Events
Primrose Bio joined global leaders in Berlin for the 3rd Annual mRNA Process Development & Manufacturing Summit, showcasing our innovations in mRNA manufacturing. On Day 1, Advisor Khaled Yamout presented “Smarter RNA Polymerase Selection for Successful mRNA... 
by Primrose Bio | Apr 23, 2025 | Events
Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform...